← Back to Patent Explorer
US4762822A Expired / Lapsed US ⏱️ 0.0 years remaining

Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides

Assignee: Individual
•
Filing: 1985-08-08
•
Granted: 1988-08-09
•
Expires: 2005-08-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention discloses mother's milk substitutes containing sialic acid or a ganglioside that reduce the number of gastrointestinal disease-producing organisms in a young mammal's food and gastrointestinal tract. The invention also discloses dietary supplements and methods for reducing the number of gastrointestinal disease-producing organisms.

Inventors

  • 👤 Anna C. Ettinger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 08:18
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004; C; C07; C07H; C07H15/00; C07H15/02; C07H15/04; C07H15/10

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 43 words
An improved food for young mammals comprising a mother's milk substitute in the form of an animal feed or infant formula having N-acetylneuraminic acid or a ganglioside present at about 0.005 to about 0.1 percent of the total weight of the improved food.
Claim 2
Dependent Claim 43 words
An improved food for young mammals comprising a mother's milk substitute in the form of an animal feed or infant formula having N-acetylneuraminic acid or a ganglioside present at about 0.005 to about 0.1 percent of the total weight of the improved food.
Claim 3
Dependent Claim 36 words
The improved food according to claim 1 wherein a ganglioside is present and is selected from the group consisting of mammalian brain ganglioside extract, human milk ganglioside extract, human colostrum ganglioside extract, and ganglioside fraction GD1a.
Claim 4
Dependent Claim 39 words
The improved food according to claim 2 wherein the young mammal is a human infant, the mother's milk substitute is infant formula, and ganglioside is present at about 0.01 to 0.05 percent of the weight of the milk substitute.
Claim 5
Dependent Claim 50 words
The improved food according to claim 2 wherein the infant formula contains about 90 weight percent water, about 1.5 to 2.0 weight percent protein, about 6.8 to about 7.2 weight percent carbohydrate, about 3.6 to 3.8 weight percent fat and about 0.3 to 0.4 weight percent minerals measured as ash.
Claim 6
Dependent Claim 46 words
The improved food according to claim 4 wherein the protein is selected from the group consisting of soy isolate and nonfat milk; the carbohydrate is selected from the group consisting of lactose, sucrose, corn syrup, corn starch, and tapioca dextrin; and said formula additionally contains vitamins.
Claim 7
Dependent Claim 42 words
The improved food according to claim 1 wherein the young mammal is a non-human mammal, the milk substitute is animal feed and N-acetylneuraminic acid or a ganglioside is present at about 0.01 to 0.05 percent of the total weight of the feed.
Claim 8
Dependent Claim 23 words
A dietary supplement comprising a unit dose of N-acetylneuramine acid or a ganglioside present in an effective amount in a physiologically tolerable excipient.
Claim 9
Dependent Claim 23 words
A dietary supplement comprising a unit dose of N-acetylneuramine acid or a ganglioside present in an effective amount in a physiologically tolerable excipient.
Claim 10
Dependent Claim 37 words
The supplement according to claim 7 wherein a ganglioside is present and is selected from the group consisting of a mammalian brain ganglioside extract and human milk ganglioside extract, human colostrum ganglioside extract and ganglioside fraction GD1a.
Claim 11
Independent Claim 36 words
A method for reducing the number of gastrointestinal disease-producing organisms comprising substantially homogeneously admixing about 0.005 to about 0.1 percent of the total food weight of N-actylneuraminic acid or a ganglioside to a young mammal's food.
Claim 12
Independent Claim 36 words
A method for reducing the number of gastrointestinal disease-producing organisms comprising substantially homogeneously admixing about 0.005 to about 0.1 percent of the total food weight of N-actylneuraminic acid or a ganglioside to a young mammal's food.
Claim 13
Dependent Claim 35 words
The method according to claim 9 wherein a ganglioside is present and is selected from the group consisting of mammalian brain ganglioside extract, human milk ganglioside extract, human colostrum ganglioside extract and ganglioside fraction GD1a.
Claim 14
Dependent Claim 21 words
The method according to claim 9 wherein the number of gastrointestinal disease-producing organisms in said young mammal's gastrointestinal tract is reduced.
Claim 15
Independent Claim 52 words
A method for conferring antimicrobial activity on a mother's milk substitute in the form of animal feed or infant formula comprising substantially homogeneously admixing N-acetylneuraminic acid or a ganglioside to said mother's milk substitute in an amount of about 0.005 to about 0.1 percent of the total weight of the milk substitute.
Claim 16
Independent Claim 52 words
A method for conferring antimicrobial activity on a mother's milk substitute in the form of animal feed or infant formula comprising substantially homogeneously admixing N-acetylneuraminic acid or a ganglioside to said mother's milk substitute in an amount of about 0.005 to about 0.1 percent of the total weight of the milk substitute.
Claim 17
Dependent Claim 35 words
The method according to claim 12 wherein a ganglioside is present and is selected from the group consisting of mammalian brain ganglioside extract, human milk ganglioside extract, human colostrum ganglioside extract and ganglioside fraction GD1a.

References Cited (Backward Citations)

US4347244A Cited
US4447600A Cited
US4476119A Cited
US4525459A Cited
US4459286A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-08-09 1992-02-08 1992-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-08-09 1996-02-08 1996-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-08-09 2000-02-08 2000-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag